TY - T1的预后评分对大血管闭塞中风JF -神经学乔-神经病学SP - S79 LP - S90做- 10.1212 / WNL。首页0000000000012797六世- 97 - 20补充2非盟-赛义德·阿里·Raza盟Srikant Rangaraju Y1 - 2021/11/16 UR - //www.ez-admanager.com/content/97/首页20_Supplement_2/S79.abstract N2 -目的评估血管内血栓切除术(EVT)大血管闭塞治疗中风(LVOS)提出了一些挑战。我们为病人提供的总结现有工具选择(pre-EVT工具)和长期预测的结果后再灌注疗法(post-EVT工具)。最近发现最近发表的随机试验证明的优越性EVT LVOS单独药物治疗。统一的病人选择范式基于人口统计学、临床和影像学变量还没有完全的标准化,导致病人选择的可变性EVT LVOS。Post-EVT,准确评估预后的长期决策过程中是至关重要的。总结预后评分可以作为有用的兼职教授,以促进临床决策在早期缺血性中风患者的管理,特别是LVOS。急性LVOS管理包括快速临床评估,分类,和脑血管成像,其次是评价为溶栓和EVT的候选资格。Pre-EVT预后的工具,准确地预测受益EVT的可能性可引导可靠、高效和划算的病人选择。EVT之后,赤字和亚急性卒中后并发症严重中风,预示着预后不良可能侵入性治疗。关于这些治疗方案涉及临床决策谨慎的提供者和病人家属之间的讨论,并基于预后提供临床医师的治疗。 Reliable post-EVT prognostic tools can facilitate this by providing accurate and objective prognostic information. Several prognostic tools have been developed and validated in the literature, some of which may be applicable in the pre-EVT and post-EVT settings, although clinical utility and application varies. Validation in contemporary datasets as well as implementation and impact studies are needed before these scales can be used to guide clinical decisions for individual patients.ASPECTS=Alberta Stroke Program Early CT Score; AUC=area under the curve; BAO=basilar artery occlusion; CSC=comprehensive stroke center; EVT=endovascular thrombectomy; FIV=final infarct volume; HERMES=Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials; HIAT=Houston Intra-Arterial Therapy; IMS-III=Interventional Management of Stroke III; IScore=Ischemic Stroke Predictive Risk Score; LSW=last seen well; LVOS=large vessel occlusion stroke; mRS=modified Rankin Scale; mTICI=modified Thrombolysis in Cerebral Infarction; NIHSS=National Institutes of Health Stroke Scale; NNR=number needed to reperfuse; NPV=negative predictive value; PH=parenchymal hemorrhage; POST=Pittsburgh Outcomes After Stroke Thrombectomy; POST-VB=Pittsburgh Outcomes After Stroke Thrombectomy Vertebrobasilar; PPV=positive predictive value; PRE=Pittsburgh Response to Endovascular Therapy; RCT=randomized controlled trial; ROC=receiver operator characteristic; SPAN=Stroke Prognostication Using Age and NIHSS; THRIVE=Totaled Health Risks in Vascular Events; tPA=tissue plasminogen activator; UW-mRS=utility-weighted modified Rankin Scale ER -